Aaron D. Levine

发表

Novel supply chain and process modeling for cell therapy manufacturing and distribution

Ben Wang, Kan Wang, Brian Liu, 2019 .

Navigating Bioethical Waters: Two Pilot Projects in Problem-Based Learning for Future Bioscience and Biotechnology Professionals

Matthew J. Drake, Robert Kirkman, Aaron D. Levine, 2016, Sci. Eng. Ethics.

A bibliometric measure of translational science

John P. Walsh, Yeon Hak Kim, Eric J. Nehl, 2020, Scientometrics.

Policy uncertainty and the conduct of stem cell research.

Aaron D. Levine, Aaron D Levine, A. Levine, 2011, Cell stem cell.

Conflicts of Interest and Effective Oversight of Assisted Reproduction Using Donated Oocytes

Aaron D. Levine, M. McGowan, Valarie K. Blake, 2015, Journal of Law, Medicine & Ethics.

Infusing Ethics into the Development of Engineers : Exemplary Education Activities and Programs

Matthew J. Drake, Robert Kirkman, Aaron D. Levine, 2016 .

Assessing the use of assisted reproductive technology in the United States by non-United States residents.

Aaron D. Levine, D. Kissin, S. Boulet, 2017, Fertility and sterility.

The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies

Aaron D. Levine, L. Wolf, A. Levine, 2012, Journal of Law, Medicine & Ethics.

Science, ethics and communication remain essential for the success of cell-based therapies

Aaron D. Levine, J. Rasko, C. Bollard, 2016, Brain circulation.

A CASE FOR GOVERNMENT-SPONSORED MONITORING OF PREIMPLANTATION GENETIC DIAGNOSIS IN THE UNITED STATES

Aaron D. Levine, 2005 .

Navigating ethical challenges in the development and translation of biomaterials research

Aaron D. Levine, Michael D. Hunckler, A. Levine, 2022, Frontiers in Bioengineering and Biotechnology.

Challenges in the translation and commercialization of cell therapies

Aaron D. Levine, B. Dodson, A. Levine, 2015, BMC Biotechnology.

Challenges in the translation and commercialization of cellular therapies

Aaron D. Levine, B. Dodson, A. Levine, 2015 .

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.

Aaron D. Levine, J. Rasko, C. Mason, 2015, Cytotherapy.

Revisiting the Warnock rule

Aaron D. Levine, R. Lovell-Badge, J. Lunshof, 2017, Nature Biotechnology.

The Oversight and Practice of Oocyte Donation in the United States, United Kingdom and Canada

Aaron D. Levine, 2011, HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues.

Risk Disclosure and the Recruitment of Oocyte Donors: Are Advertisers Telling the Full Story?

Aaron D. Levine, R. Berry, H. Alberta, 2014, Journal of Law, Medicine & Ethics.

Self-Regulation, Compensation, and the Ethical Recruitment of Oocyte Donors

Aaron D. Levine, A. Levine, 2010, The Hastings Center report.

Compliance with donor age recommendations in oocyte donor recruitment advertisements in the USA.

Aaron D. Levine, R. Berry, H. Alberta, 2013, Reproductive biomedicine online.

Part 6: The role of communication in better understanding unproven cellular therapies.

Aaron D. Levine, L. Turner, L. O’Donnell, 2016, Cytotherapy.

Tracking the rise of stem cell tourism.

Aaron D. Levine, Aaron D Levine, Kirsten A Ryan, 2010, Regenerative medicine.

Self-Regulation, Compensation, and the Ethical Recruitment of Oocyte Donors

Aaron D. Levine, 2010 .

State performance in pluripotent and adult stem cell research, 2009-2016.

Aaron D. Levine, Sana H Surani, A. Levine, 2018, Regenerative medicine.

Ethical Considerations in the Translation of CAR-T Cell Therapies

Aaron D. Levine, Arjun Patel, Kathleen J. Imbach, 2018 .

Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic

Aaron D. Levine, L. Ikonomou, L. Turner, 2021, Stem Cell Reports.

Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014

Aaron D. Levine, D. Kissin, S. Boulet, 2017, JAMA.

Trends in the geographic distribution of human embryonic stem-cell research

Aaron D. Levine, A. Levine, 2004, Politics and the Life Sciences.

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions.

Aaron D. Levine, D. Weiss, L. Ikonomou, 2018, Cytotherapy.

Research policy and the mobility of US stem cell scientists

Aaron D. Levine, 2006, Nature Biotechnology.

Tracking and assessing the rise of state-funded stem cell research

Aaron D. Levine, R. Karmali, Natalie M Jones, 2010, Nature Biotechnology.

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies.

Ben Wang, Kan Wang, Chip White, 2019, Cytotherapy.

Differences in the utilization of gestational surrogacy between states in the U.S.

Aaron D. Levine, D. Kissin, S. Boulet, 2017, Reproductive biomedicine & society online.